Therini Bio

Sacramento, CA · Founded 2016 · Privately Held (backing)

Developer of biotechnology drugs designed to offer a potential treatment to protect the nervous system from multiple sclerosis damage. Therini Bio is based in Sacramento, CA and was founded in 2016. It was valued at $100 million at its later-stage round in May 2025, the last priced event on record. It has raised $102 million across 2 recorded rounds; the latest was a $74.9 million later-stage round in Mar 2023.

PMV mark · valuation
$100.0M
Oct 2026
Priced at
its later-stage round
May 2025
Total raised
$101.5M
Last round
Later Stage VC
Mar 2023

Who backs Therini Bio?

15 investors
InvestorType
National Institutes of HealthOther
University of CaliforniaOther
Dolby Family VenturesVenture capital
SV Health InvestorsVenture capital
Angelini VenturesVenture capital
Alzheimers Drug Discovery Foundation—
Apollo Health Ventures—
Blue Goose Capital—
Dreavent—
Eli Lilly—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Therini Bio investors

15 investors are on record for Therini Bio, including National Institutes of Health, University of California, Dolby Family Ventures and SV Health Investors. The later-stage round in Mar 2023 drew 17 investors.

Free account
More of Therini Bio with a free account
  • ·The complete investor list: 15 names
  • ·Watch Therini Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like Therini Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View